Original Article

You have full text access to this OnlineOpen article

Breast implant-associated, ALK-negative, T-cell, anaplastic, large-cell lymphoma: Establishment and characterization of a model cell line (TLBR-1) for this newly emerging clinical entity†

  1. Melissa G. Lechner BA1,
  2. Stephen Lade MD2,
  3. Daniel J. Liebertz MD1,
  4. H. Miles Prince MD2,
  5. Garry S. Brody MD3,
  6. Howard R. Webster MD4,
  7. Alan L. Epstein MD, PhD1,‡,*

Article first published online: 8 NOV 2010

DOI: 10.1002/cncr.25654

Issue

Cancer

Cancer

Volume 117, Issue 7, pages 1478–1489, 1 April 2011

Additional Information

How to Cite

Lechner, M. G., Lade, S., Liebertz, D. J., Prince, H. M., Brody, G. S., Webster, H. R. and Epstein, A. L. (2011), Breast implant-associated, ALK-negative, T-cell, anaplastic, large-cell lymphoma: Establishment and characterization of a model cell line (TLBR-1) for this newly emerging clinical entity. Cancer, 117: 1478–1489. doi: 10.1002/cncr.25654

Author Information

  1. 1

    Pathology Department, USC Keck School of Medicine, Los Angeles, California

  2. 2

    Division of Hematology and Medical Oncology, Peter MacCallum Cancer Center, University of Melbourne, Victoria, Australia

  3. 3

    Plastic Surgery Department, University of Southern California Keck School of Medicine, Los Angeles, California

  4. 4

    ARC Plastic Surgery, University of Melbourne, Victoria, Australia

  1. ‡

    Fax: (323) 442-3049

*Pathology Department, Hoffman Medical Research Building Room 205, USC Keck School of Medicine, Los Angeles, CA 90033

  1. †

    M.G.L. characterized the TLBR-1 cell line, analyzed the data, and wrote the article. S.L., H.M.P., and H.R.W. provided clinical care and management of the patient, performed clinical studies on the original biopsy specimen, and wrote the case report. D.J.L. assisted with polymerase chain reaction (PCR) and qRT-PCR analyses and prepared the figures. G.S.B. identified the patient and arranged for transport of the biopsy specimen. A.L.E. established the cell line and supervised the studies. All authors reviewed the manuscript.

Publication History

  1. Issue published online: 18 MAR 2011
  2. Article first published online: 8 NOV 2010
  3. Manuscript Accepted: 9 AUG 2010
  4. Manuscript Revised: 22 JUN 2010
  5. Manuscript Received: 22 MAR 2010

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (747K)

REFERENCES

  • 1
    Bishara MR, Ross C, Sur M. Primary anaplastic large cell lymphoma of the breast arising in reconstruction mammoplasty capsule of saline filled breast implant after radical mastectomy for breast cancer: an unusual case presentation. Diagn Pathol. 2009; 4: 11.
  • 2
    Newman MK, Zemmel NJ, Bandak AZ, Kaplan BJ. Primary breast lymphoma in a patient with silicone breast implants: a case report and review of the literature. J Plast Reconstr Aesthet Surg. 2008; 61: 822-825.
  • 3
    Wong AK, Lopategui J, Clancy S, Kulber D, Bose S. Anaplastic large cell lymphoma associated with a breast implant capsule: a case report and review of the literature. Am J Surg Pathol. 2008; 32: 1265-128.
  • 4
    Fritzsche FR, Pahl S, Petersen I, et al. Anaplastic large-cell non-Hodgkin's lymphoma of the breast in periprosthetic localisation 32 years after treatment for primary breast cancer–a case report. Virchows Arch. 2006; 449: 561-564.
  • 5
    Sahoo S, Rosen PP, Feddersen RM, Viswanatha DS, Clark DA, Chadburn A. Anaplastic large cell lymphoma arising in a silicone breast implant capsule: a case report and review of the literature. Arch Pathol Lab Med. 2003; 127: e115-8.
  • 6
    Roden AC, Macon WR, Keeney GL, Myers JL, Feldman AL, Dogan A. Seroma-associated primary anaplastic large-cell lymphoma adjacent to breast implants: an indolent T-cell lymphoproliferative disorder. Mod Pathol. 2008; 21: 455-463.
  • 7
    de Jong D, Vasmel WL, de Boer JP, et al. Anaplastic large-cell lymphoma in women with breast implants. JAMA. 2008; 300: 2030-2035.
  • 8
    Lipworth L, Tarone RE, McLaughlin JK. Breast implants and lymphoma risk: a review of the epidemiologic evidence through 2008. Plast Reconstr Surg. 2009; 123: 790-793.
  • 9
    Brody GS, Deapen D, Gill P, Epstein A, Martin S, Elatra W. T cell non-Hodgkin's anaplastic lymphoma associated with one style of breast implants. San Antonio, Texas: American Society of Plastic Surgeons Annual Conference, March 20-23, 2010. Scientific Session IX: Breast B, Oral communication and abstract 42.
  • 10
    Stein H, Mason DY, Gerdes J, et al. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood. 1985; 66: 848-858.
  • 11
    Kempf W. CD30+ lymphoproliferative disorders: histopathology, differential diagnosis, new variants, and simulators. J Cutan Pathol. 2006; 33(suppl 1): 58-70.
    Direct Link:
  • 12
    Rosen ST, Querfeld C. Primary cutaneous T-cell lymphomas. Hematology Am Soc Hematol Educ Program. 2006: 323-30.
  • 13
    Falini B, Martelli MP. Anaplastic large cell lymphoma: changes in the World Health Organization classification and perspectives for targeted therapy. Haematologica. 2009; 94: 897-900.
  • 14
    Querfeld C, Kuzel TM, Guitart J, Rosen ST. Primary cutaneous CD30+ lymphoproliferative disorders: new insights into biology and therapy. Oncology. 2007; 21: 689-700.
  • 15
    Lamant L, Espinos E, Duplantier M, et al. Establishment of a novel anaplastic large-cell lymphoma-cell line (COST) from a ‘small-cell variant’ of ALCL. Leukemia. 2004; 18: 1693-1698.
  • 16
    Juco J, Holden JT, Mann KP, Kelley LG, Li S. Immunophenotypic analysis of anaplastic large cell lymphoma by flow cytometry. Am J Clin Pathol. 2003; 119: 205-212.
  • 17
    Herbst H, Drexler HG. CD30-Positive Anaplastic Large Cell Lymphoma Cell Lines. In: JRWMasters, PalssonBO, eds. Human Cell Culture: Cancer Cell Lines, pt 3: Leukemias and Lymphomas. Vol 3. Netherlands: Springer; 2000: 355-370.
  • 18
    Theriault C, Galoin S, Valmary S, et al. PCR analysis of immunoglobulin heavy chain (IgH) and TcR-gamma chain gene rearrangements in the diagnosis of lymphoproliferative disorders: results of a study of 525 cases. Mod Pathol. 2000; 13: 1269-1279.
  • 19
    Ferrando AA, Look AT. Gene expression profiling in T-cell acute lymphoblastic leukemia. Semin Hematol. 2003; 40: 274-280.
  • 20
    Jundt F, Anagnostopoulos I, Forster R, Mathas S, Stein H, Dorken B. Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma. Blood. 2002; 99: 3398-3403.
  • 21
    Epstein AL, Kaplan HS. Feeder layer and nutritional requirements for the establishment and cloning of human malignant lymphoma cell lines. Cancer Res. 1979; 39: 1748-1759.
  • 22
    Venard V, Carret AS, Pascal N, Rihn B, Bordigoni P, Le Faou A. A convenient semi-quantitative method for the diagnosis of Epstein-Barr virus reactivation. Arch Virol. 2000; 145: 2211-2216.
  • 23
    Pawson R, Schulz TF, Matutes E, Catovsky D. The human T-cell lymphotropic viruses types I/II are not involved in T prolymphocytic leukemia and large granular lymphocytic leukemia. Leukemia. 1997; 11: 1305-1311.
  • 24
    Cui W, Taub DD, Gardner K. qPrimerDepot: a primer database for quantitative real time PCR. Nucleic Acids Res. 2007; 35: D805-D809.
  • 25
    Drexler HG. The Leukemia-Lymphoma Cell Line Facts Book. San Diego: Academic Press; 2001: 487-503.
  • 26
    Turbat-Herrera EA, Veillon D, Cotelingam J, Fowler M, Herrera GA. The ultrastructural and immunohistochemical heterogeneity of CD30-positive neoplasms: so-called anaplastic large cell Ki-1 lymphomas. Med Electron Microsc. 2001; 34: 19-28.
  • 27
    Allenspach EJ, Maillard I, Aster JC, Pear WS. Notch signaling in cancer. Cancer Biol Ther. 2002; 1: 466-476.
View Full Article (HTML) Get PDF (747K)